CryoLife (AORT): Market Cap to Revenue

Symbol and logo of brand CryoLife (AORT)

The company's price-to-sales ratio demonstrates the resilience of Artivion, Inc. (AORT) driven by global sales of bioprostheses and vascular adhesives. The current status is 1.90. R&D expenses and the risk of product quality litigation are weighing on the dynamics. Stability is further supported by a standardized approach to biomaterial utilization and strict adherence to sterility standards.

AORT CryoLife P/S Multiple (07/04/2022 - 11/17/2026)

Analytical breakdowns for artivion.com (AORT)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:AORT CryoLife
Core merchandise of Artivion, Inc.

Artivion, Inc. (AORT) operates as a developer of high-tech cardiac surgery devices, which necessitates significant investment in biomedical capital and stringent quality control. An analysis of the median P/S ratio, reflecting the relationship between market capitalization and annual revenue, allows for the determination of the asset's overvaluation relative to its fundamental earnings and helps identify optimal entry points or the need to hedge against downside risks.

Competitors of Artivion, Inc.

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|ZBH (zimmerbiomet.com) - Market Cap to Revenue Ratio|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (NuVasive) - P/S Multiple|TransMedics Corp (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Enovis Corporation ENOV|P/S Multiple IART (integralife.com)|P/S Multiple Establishment Labs Corp ESTA|BBNX - Price-to-Revenue Ratio|IRMD: Price-to-Revenue Ratio|EMBC (Embecta Corp.) - Market Cap to Revenue|Tandem Diabetes Care - Market Capitalization-to-Revenue Ratio|AXGN (Axogen Surgical) - P/S Multiple|Price to Sales SI-BONE Inc SIBN|Price-to-Revenue Ratio Orthofix Medical (OFIX)|P/S Multiple Bioventus Corp (BVS)|OrthoPediatrics Corp - Market Cap to Revenue|P/S Multiple Treace Medical Concepts TMCI|Blade Air Mobility - P/S Multiple|Price-to-Revenue Coefficient Carlsmed, Inc. CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint)|Price-to-Revenue Ratio stereotaxis.com|Market Cap to Revenue Neuronetics, Inc. (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio anikatherapeutics.com ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical Inc - Market Cap to Sales Volume|XTNT (Xtant Medical Holdings) - Market Cap to Revenue|Market Cap to Revenue Ratio NMTC|Price-to-Revenue Ratio Modular Medical Inc|Price to Sales Myomo Inc MYO|Market Cap to Revenue COCH (Envoy Medical, Inc.)|Price-to-Revenue Ratio VVOS (vivoslife.com)|enVVeno Medical Corp. - Market Cap to Revenue|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)